| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6cb50d89f8cb1e4d0dd566c7db4573f6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d07c340ab610a53c7c834dbc25047580
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ec57e6016f54b2b28b86215c2066e8d1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1b74695f4c6259a8598b722c1ef6eefa |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7016
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H11-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H11-00 |
| filingDate |
2018-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2021-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ab6f6e3fc50e3f4bf1f68f2f06efd6c8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_90d715c8c3ce51d269a3b7ee5df35af7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c5e21d6c45e537e13ddd39f6d0630c7c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ada75214d46080d851aca551310469a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b8a93bff69ed2679a02e0c0e46b59a8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a6b34656702bbb5a95de01dbba864cb2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_efaec905f60850326ae387447c2a81f7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a255688e72071d4b5d5dd1786b90b1d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fadd98cd9823eb520a7bd9798b0a369f |
| publicationDate |
2021-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-11046722-B2 |
| titleOfInvention |
Sulphated disaccharides for the treatment of neuropathic pain |
| abstract |
The present invention relates to sulphated disaccharides of formula (I) for use in the treatment of neuropathic pain. The present invention also relates to a pharmaceutical composition comprising the compound of formula (I) and at least one pharmaceutically acceptable excipient for use in the treatment of neuropathic pain. The compounds of formula (I) were effective in several experimental models of neuropathic pain for which reason these compounds can be used effectively for the treatment of different types of neuropathic pain and the clinical manifestations thereof, for example, mechanical allodynia or cold allodynia. |
| priorityDate |
2017-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |